Concepedia

Asher Chanan-Khan

AC

Statistics

Publications

4

Citations

703

H-Index

4

Active since

2005

Affiliations

Moffitt Cancer Center(Current)

City of Hope

The Ohio State University

Roswell Park Comprehensive Cancer Center

Asher Chanan-Khan is an author at Moffitt Cancer Center specializing in cancer research, radiation oncology, and oncology.

Top concepts

Publications per year

2005–2021

4

Publications

4

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

John C. Byrd, Peter Hillmen, Paolo Ghia et al. · Journal of Clinical Oncology · 2021 · 594 citations · Full text

Cancer- and Treatment-Related Anemia Clinical Practice Guidelines in Oncology

George M. Rodgers, David Cella, Asher Chanan-Khan et al. · Journal of the National Comprehensive Cancer Network · 2005 · 62 citations · Full text

, , +14

Phase I study of lorvotuzumab mertansine (LM, IMGN901) in combination with lenalidomide (Len) and dexamethasone (Dex) in patients with CD56-positive relapsed or relapsed/refractory multiple myeloma (MM).

J. G. Berdeja, Sikander Ailawadhi, Steven Weitman et al. · Journal of Clinical Oncology · 2011 · 36 citations

, , +17

Phase 1 clinical trial of KOS-953 + bortezomib (BZ) in relapsed refractory multiple myeloma (MM)

Asher Chanan-Khan, Paul G. Richardson, Melissa Alsina et al. · Journal of Clinical Oncology · 2006 · 11 citations

, , +18

1–4 of 4